---
figid: PMC8187902__fonc-11-651541-g002
figtitle: 'Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy
  of the Molecular Mechanisms'
organisms:
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- mixed culture
pmcid: PMC8187902
filename: fonc-11-651541-g002.jpg
figlink: /pmc/articles/PMC8187902/figure/f2/
number: F2
caption: 'Resistance to CDK4/6 inhibitors: Direct Cell Cycle Mechanism: 1. Loss of
  drug target genes: APC/CFZR1 promote the phosphorylation of Rb1 and regulate cell
  transition from G1 to S. knockdown of Rb1 and FZR1 synergistically bypassed cell
  division arrest induced by the CDK4/6 inhibitor (–); 2. Increased activity of the
  CDK4 and CDK6: amplification of CDK4/6 account for a decreased CDK4/6 targeted phosphorylation
  of Rb1 and a decreased sensitivity of breast cancer cells to CDK4/6 inhibitor (,
  –); 3. Abnormal regulations of upstream and Downstream kinases: CCNE1/CDK2, CDK7,
  E2F, INK, PTEN, Smad-TGF-β pathway which are involved in the progression of cell
  cycle, as shown in , are responsible for resistance to CDK4/6 inhibitors (, , ,
  , –); 4. Activation of alternate genes like HDACS, WEE1, MDM2, partly help the cancer
  cell escape from the drugs work (–).'
papertitle: 'Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors:
  Intricacy of the Molecular Mechanisms.'
reftext: Bin Wang, et al. Front Oncol. 2021;11:651541.
year: '2021'
doi: 10.3389/fonc.2021.651541
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: breast cancer | CDK4/6 inhibitors | drug resistance | molecular mechanisms
  | combination administration
automl_pathway: 0.9594177
figid_alias: PMC8187902__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
redirect_from: /figures/PMC8187902__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8187902__fonc-11-651541-g002.html
  '@type': Dataset
  description: 'Resistance to CDK4/6 inhibitors: Direct Cell Cycle Mechanism: 1. Loss
    of drug target genes: APC/CFZR1 promote the phosphorylation of Rb1 and regulate
    cell transition from G1 to S. knockdown of Rb1 and FZR1 synergistically bypassed
    cell division arrest induced by the CDK4/6 inhibitor (–); 2. Increased activity
    of the CDK4 and CDK6: amplification of CDK4/6 account for a decreased CDK4/6 targeted
    phosphorylation of Rb1 and a decreased sensitivity of breast cancer cells to CDK4/6
    inhibitor (, –); 3. Abnormal regulations of upstream and Downstream kinases: CCNE1/CDK2,
    CDK7, E2F, INK, PTEN, Smad-TGF-β pathway which are involved in the progression
    of cell cycle, as shown in , are responsible for resistance to CDK4/6 inhibitors
    (, , , , –); 4. Activation of alternate genes like HDACS, WEE1, MDM2, partly help
    the cancer cell escape from the drugs work (–).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CCNH
  - WEE1
  - MNAT1
  - PEA15
  - ALG1
  - MSC-AS1
  - ACAT1
  - MAT1A
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - CDK7
  - CCNE1
  - CDK2
  - RB1
  - RBM45
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - WARS1
  - CDK6
  - CDK4
  - CDK1
  - CDKN2A
  - H3P10
  - APC
  - PROC
  - VEGFA
  - FZR1
  - MIR372
  - TP53
  - TP63
  - TP73
  - MDM2
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Ccnh
  - Wee1
  - Matn1
  - Mnat1
  - Pea15a
  - Mat1a
  - Mmp7
  - Pik3r1
  - Pten
  - Cdk7
  - pr
  - Ccne1
  - Cdk2
  - Rb1
  - Gabrg2
  - Cdk6
  - Cdk4
  - Cdk1
  - Cdkn2a
  - Cyp2b10
  - Rbm14
  - Apc
  - Vegfa
  - Fzr1
  - Trp53
  - Mdm2
  - mat-1
  - cdk-7
  - cdk-2
  - cdk-4
  - cdk-1
  - fzr-1
---
